| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/11/2008 | US7342061 Method for producing organic compounds containing poly-DOPO, and the use of the same |
| 03/11/2008 | US7342060 Ester interchange of pentaerythritol with monophosphite and phenol; controlling temperature, pressure |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7341985 2-Hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents |
| 03/06/2008 | WO2008027604A2 Production processes and systems, compositions, surfactants monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams and foam stabilizers |
| 03/06/2008 | WO2008027536A1 Oligomeric bis-phosphate flame retardants and compositions containing the same |
| 03/06/2008 | WO2008026602A1 Heteroacene derivative, tetrahaloterphenyl derivative, and their production methods |
| 03/06/2008 | WO2008026470A1 Imide complex, method for producing the same, metal-containing thin film and method for producing the same |
| 03/06/2008 | WO2008026309A1 Novel microorganism capable of degrading diphenylarsinic acid |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2008025673A1 New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions |
| 03/06/2008 | WO2008005964A3 Phosphonate and phosphinate compounds as glucokinase activators |
| 03/06/2008 | WO2007149829A3 Therapeutic compounds |
| 03/06/2008 | WO2007112028A3 2'-fluoronucleoside phosphonates as antiviral agents |
| 03/06/2008 | WO2007098182A3 Phosphonylated fluorescent dyes and conjugates |
| 03/06/2008 | US20080058546 Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/06/2008 | US20080057031 Antiviral phosphinate compounds |
| 03/06/2008 | US20080054223 Light Emitting Complex Salts |
| 03/05/2008 | EP1894938A1 New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions |
| 03/05/2008 | EP1894937A1 Tantalum and niobium compounds and their application in Chemical Vapour Deposition (CVD) |
| 03/05/2008 | EP1417212B1 NOVEL PHOSPHITE COMPOUNDS AND Rh-COMPLEXES THEREOF |
| 03/05/2008 | CN101137639A Flavonoid compounds and uses thereof |
| 03/05/2008 | CN101134765A Method for synthesizing adefovir dipivoxil ester |
| 03/05/2008 | CN101134764A Method for synthesizing target compound-ligustrazine derivant preventing cerebrovascular disease |
| 03/05/2008 | CN101134763A Method for preparing tetra hydroxymethyl phosphorus trichloride-urea primary condensed polymer |
| 03/05/2008 | CN101134762A Method for refining 0,0-diethyl sulfo-phosphoryl chloride |
| 03/05/2008 | CN100372857C Production process of N-phosphono methyl glycine |
| 03/04/2008 | US7338735 Organic electrolytic solution and lithium-sulfur battery comprising the same |
| 02/28/2008 | WO2008025025A2 Antisense composition and method for inhibition of mirna biogenesis |
| 02/28/2008 | WO2008022919A1 Use of phosphoric triamides in toilets |
| 02/28/2008 | WO2008022771A1 Amides as sphingomyeline inhibitors |
| 02/28/2008 | WO2007139729A8 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 02/28/2008 | US20080051607 Organic electroluminescent devices, aminostyrlnaphthalene compounds and synthesis intermediates thereof, and production processes of the same |
| 02/28/2008 | US20080051480 Modified Ion Exchange Resin and Process for Producing Bisphenols |
| 02/28/2008 | US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use |
| 02/28/2008 | CA2661608A1 Use of phosphoric triamides in toilets |
| 02/28/2008 | CA2660524A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2659991A1 Amides as sphingomyeline inhibitors |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1891082A1 Novel inhibitors of pyruvate kinase as therapeutic agents for cancer |
| 02/27/2008 | EP1891081A1 Process for producing bisphosphonic acids and forms thereof |
| 02/27/2008 | EP1891080A2 Novel phosphorus-containing thyromimetics |
| 02/27/2008 | EP1890706A2 Process for the preparation and isolation of phosphatides |
| 02/27/2008 | EP1749032B1 Alkoxyamines containing a radically polymerizable group |
| 02/27/2008 | CN101133070A Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same |
| 02/27/2008 | CN101133055A Compositions and methods for treatment of cancer |
| 02/27/2008 | CN101131897A Aluminum electrolytic capacitor, preparing method for quaternary ammonium salt for super capacitor |
| 02/27/2008 | CN101130554A Method for processing 0,0-ethyl thioether substituted phosphorus oxychloride residual liquid |
| 02/27/2008 | CN100371338C Process for separation and purification of glyphosate from glyphosate solution by membrane technology |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/27/2008 | CN100371074C Novel catalytic formulation and its preparation method |
| 02/26/2008 | US7335799 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/26/2008 | US7335787 Salt formation; combining an alkyl, aryl or cyclohexyl iodonium salt derivative containing a halide anion or a carboxylate anion with a sulfonic acid ester, dialkylsuric acid or a phosphoric acid derivative; sulfonate, phospate or sulfate anion with an iodoinium or sulfonium alkyl cation |
| 02/26/2008 | US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | CA2300910C Phosphono-carboxylate compounds for treating amyloidosis |
| 02/21/2008 | WO2008019598A1 2,2',6,6'-tetrasubstituted aminophosphine ligand and its synthesis method |
| 02/21/2008 | WO2007110761A3 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
| 02/21/2008 | US20080045736 Water-Soluble, Surface-Functionalized Nanoparticle for Bioconjugation Via Universal Silane Coupling |
| 02/21/2008 | US20080045735 Method for Producing Phosphate Silanes |
| 02/21/2008 | US20080045719 Process for the Preparation of a Metal-Organic Compound Comprising at Least One Imine Ligand |
| 02/21/2008 | US20080045705 2-oxoethyl(1R)-4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-[[3,5-dimethyl-4-(phenylmethoxy)phenyl]methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-1-piperidinecarboxylate; coupling alpha -hydroxy-3,5-dimethyl-4-(phenylmethoxy)-phenylpropionic acid-monosodium salt with 1,3-benzodiazepin compound |
| 02/21/2008 | US20080045673 Process for Preparing Diaryl Alkylphosphonates and Oligomeric/Polymeric Derivatives Thereof |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/21/2008 | US20080045481 Novel co-crystal |
| 02/21/2008 | US20080045465 Phosphole Derivatives Complexed with Metals, and Pharmaceutical Uses Thereof |
| 02/21/2008 | US20080044923 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na |
| 02/21/2008 | US20080044487 Anti-inflammatory properties of marine lipid compositions |
| 02/20/2008 | EP1888771A2 Method for determining phytase activity |
| 02/20/2008 | EP1888606A2 Process and novel salt |
| 02/20/2008 | EP1888605A1 Low-viscosity ionic liquids |
| 02/20/2008 | EP1888604A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 02/20/2008 | EP1565425B1 Production process of a lactate ester or acid |
| 02/20/2008 | EP1421092A4 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 02/20/2008 | CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase |
| 02/20/2008 | CN101125863A Preparation method for alendronic acid |
| 02/20/2008 | CN101125862A Circulation recovery method for glyphosate mother liquid |
| 02/20/2008 | CN101125861A Method for synthesizing aliphatic alcohol polyoxyvinethene phosphate |
| 02/20/2008 | CN100369940C Catalysts for olefin polymerization |
| 02/20/2008 | CN100369924C Polycyclic, phosphorous-contg. jingang hydroxylamine-A compound, prepn. method and application thereof |
| 02/20/2008 | CN100369923C Fluorinated phosphonic acids |
| 02/20/2008 | CN100369922C Methamidophos half-antigen, artificial antigen and its preparing method |
| 02/19/2008 | US7332618 Organometallic precursor compounds |
| 02/19/2008 | US7332603 Preparation of biphosphonic acids and salts thereof |
| 02/19/2008 | US7332553 Functional monomers for molecular recognition and catalysis |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/14/2008 | WO2008019111A2 Telomer compositions and production processes |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018195A1 Polymer having bis(diphenylphosphino)binaphthyl group |
| 02/14/2008 | WO2008017339A1 α-AMINO ACID PHOSPHONIC ACID COMPOUNDS, METHOD OF PREPARATION AND USE THEREOF |
| 02/14/2008 | WO2007147222A9 Novel ionic liquids |
| 02/14/2008 | WO2007078859B1 Tetraphosphorus ligands for catalytic hydroformylation and related reactions |
| 02/14/2008 | US20080039634 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/14/2008 | US20080039620 3'-End Nucleoside Unit Comprising Phosphoramidite |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |